News and Announcements
- June 15, 2017
TCGA study of liver cancer reveals potential targets for therapy
Researchers in The Cancer Genome Atlas (TCGA) Research Network performed an integrative study of 196 liver cancer genomes and identified targets for therapies that are currently available or under development.
- March 14, 2017
TCGA Investigators Improve Understanding of the Molecular Drivers of Cholangiocarcinoma
Investigators with The Cancer Genome Atlas (TCGA) Research Network characterized 58 cholangiocarcinomas, rare cancers of bile ducts, and identified a new subtype characterized by mutation of the IDH gene.
- March 13, 2017
TCGA Study of Rare Uterine Cancer Identifies Molecular Features
The Cancer Genome Atlas (TCGA) Research Network comprehensively characterized 57 uterine carcinosarcomas and found that these rare cancers share molecular features with both sarcomas and carcinomas.
- February 02, 2017
TCGA study identifies four subtypes of rare nervous system cancers
Researchers with The Cancer Genome Atlas Network determined that pheochromocytomas (PCC) and paragangliomas (PGL) can be classified into four distinct subtypes and also found several novel alterations never before seen in these rare cancers of the autonomic nervous system.
- January 23, 2017
TCGA study identifies genomic features of cervical cancer
TCGA's comprehensive analysis of cervical cancer found genomic alterations that may help target therapies, and revealed a small subset of tumors that were not linked to human papillomavirus (HPV) infection. Photo Credit: The Cancer Genome Atlas et al. Nature. [CC-BY-4.0]
- January 04, 2017
TCGA study of esophageal cancers finds features that aid in their classification
A new study by The Cancer Genome Atlas Research Network found genomic differences between the two most common types of esophageal cancer that help place them in the spectrum of cancers from the stomach to the head and neck.
Image Credit: Toshinori Hinoue, Ryo Sakai, Peter W. Laird
- June 06, 2016
Newly launched Genomic Data Commons to facilitate data and clinical information sharing
The Genomic Data Commons (GDC) is a data sharing platform that promotes precision medicine in oncology, and it will host all of the TCGA data.
- May 09, 2016
Analysis of rare endocrine cancer reveals novel genetic alterations
In the most comprehensive molecular characterization to date of adrenocortical carcinoma, a rare cancer of the adrenal cortex, researchers extensively analyzed 91 cases for alterations in the tumor genomes.
- November 05, 2015
TCGA study identifies seven distinct subytypes of prostate cancer
A comprehensive analysis of 333 prostate cancers identified key genetic alterations that may help improve classification and treatment of the disease.
- November 04, 2015
Improved understanding of the genetic drivers of papillary renal cell carcinoma
A comprehensive genomic analysis of 161 tumors from people with papillary renal cell carcinoma (PRCC) – the second most common form of kidney cancer –provided insights into the molecular basis of this cancer and may inform its classification and treatment.
1
2 3 Next >
